The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent.
Naroa Goikoetxea-Usandizaga,Miren Bravo,Leire Egia-Mendikute,Leticia Abecia,Marina Serrano-Maciá,Rocío G Urdinguio,Marc Clos-García,Rubén Rodríguez-Agudo,Raquel Araujo-Legido,Lucía López-Bermudo,Teresa C Delgado,Sofía Lachiondo-Ortega,Irene González-Recio,Clàudia Gil-Pitarch,Ainize Peña-Cearra,Jorge Simón,Raquel Benedé-Ubieto,Silvia Ariño,Jose M Herranz,Mikel Azkargorta, Julio Salazar-Bermeo,Nuria Martí,Marta Varela-Rey,Juan M Falcón-Pérez,Óscar Lorenzo,Rubén Nogueiras,Félix Elortza,Yulia A Nevzorova,Francisco J Cubero,Domingo Saura,Luis Alfonso Martínez-Cruz,Guadalupe Sabio,Asís Palazón,Pau Sancho-Bru,Natalia Elguezabal,Mario F Fraga,Matías A Ávila,Ramón Bataller,José J G Marín,Franz Martín,María Luz Martínez-Chantar Hepatology (Baltimore, Md.)(2023)
摘要
Improving mitochondrial respiration by liver-specific Mcj silencing might become a novel therapeutic approach for treating ALD.
更多查看译文
关键词
mitochondrial activity,liver disease,alcohol-associated,organ-dependent
AI 理解论文
溯源树
样例